Hadassah

Hadassah’s Head of Pediatrics Receives Honorary Fellowship from Royal College of Pediatrics

Tuesday, Jun 28 2016

The Center for Children with Chronic Diseases.

Prof. Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Center, Founder of its Center for Children with Chronic Diseases, and world-renowned specialist in cystic fibrosis (CF), has been awarded an Honorary Fellowship from the United Kingdom’s Royal College of Pediatrics and Child Health “in recognition of his outstanding contributions to the objectives of the College.” Royal College’s mission is to transform child health through knowledge, innovation, and expertise.

In 2014, Prof. Kerem received the prestigious European Cystic Fibrosis Society’s prize for his outstanding work in CF.

As stated by the Royal College: “Prof. Kerem has advanced child health through his work in partnership with the Palestinian community, through his pioneering work in cystic fibrosis, and his indefatigable labors for the rights of all children. His true excellence lies in his humanitarian contribution, as he has a proven record of building bridges between Israelis and Palestinians, furthering peace through medicine wherever possible, and raising the standards of health care delivery in both communities. He has been active in training Palestinian pediatricians in his cystic fibrosis clinic, and treating Palestinian children.

“Prof. Kerem is a world-known leader in cystic fibrosis research, serving as a principal investigator of many national and international clinical trials and author of key publications in the field. He was the first to demonstrate that gentamicin over-rode premature stop codons. He was also involved in formulating the guidelines that paved the road to the standardization of CF care in Europe and other parts of the world. He is a recipient of the prestigious Ordine Della Stella Della Solidarieta ltaliana Award. The European Cystic Fibrosis Society recently recognized Prof. Kerem for his vast interest in cystic fibrosis across all aspects b

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›
alt_text

Friday, Aug 2 2019

Eloxx Pharmaceuticals Announces New Drug Application for Clinical Trial in Cystic Fibrosis Patients

Professor Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Organization, will serve as the Global Lead Investigator for this clinical trial.

READ MORE ›
alt_text

Wednesday, Jul 31 2019

Skin Cancer Treatment Enhanced in New Center for Dermatologic Surgery

Thanks to a donation by the Israeli businessman and philanthropist Morris Kahn, a major supporter of the Israeli moon spacecraft “Beresheet,” Hadassah Hospital Ein Kerem has just opened the new Center for Dermatologic Surgery, which offers Mohs surgery for patients with common types of skin cancer.

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More